Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2488)	4/27/2009 12:53:47 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

SDIX has been up 21.84% but is up only 14.16% at present. Volume of 54,900 is > 5x its ADV. No news that I am aware. bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (2488)	9/28/2009 1:22:33 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NVAX is bouncing up above the $4 level with volume now above 7M but still below its ADV. It was up 17.10% earlier and is still up 14.21% at present bigcharts.marketwatch.com The stock could benefiting from an article in Forbes. NVAX was able to trim its loss in the 2ndQ in spite of its persistent lower revenues, and the loss is expected to be trimmed some this Yr and in 2010. The market for H1N1 virus vaccines remains a hot topic, with the expected 'epidemic' this flu season.<g> NAVX has modest LTD. The ACTAY is $5.50 With some good news and a close above $6 the stock could get to test again the $8 level.<g> bigcharts.marketwatch.com Bernard